Individualising dual antiplatelet therapy after percutaneous coronary intervention: the IDEAL-PCI registry. - Wikidata - awgldk - TriplyDB

Individualising dual antiplatelet therapy after percutaneous coronary intervention: the IDEAL-PCI registry.

Individualising dual antiplatelet therapy after percutaneous coronary intervention: the IDEAL-PCI registry.

http://www.wikidata.org/entity/Q34439089

about

Personalized antiplatelet therapy with P2Y12 receptor inhibitors: benefits and pitfalls Platelet aggregation and risk of stent thrombosis or bleeding in interventionally treated diabetic patients with acute coronary syndrome.Assessment of platelet function in patients with stroke using multiple electrode platelet aggregometry: a prospective observational study.Advocating cardiovascular precision medicine with P2Y12 receptor inhibitors.Abciximab as a bridging strategy to overcome morphine-prasugrel interaction in STEMI patients.The Use of Aspirin to Reduce the Risk of Thrombotic Events in Patients With End-Stage Renal Disease: Protocol for a Randomized Controlled Trial

P2860

Q26775125-77CD7E51-EA2E-44FD-A1E1-07BEE08AFC9B Q36216424-E6FF6B88-BAB8-47A7-B287-4C919E1CDC2C Q36219096-CAE78027-4792-4795-BB8D-87BC64E2D6AB Q38958862-36257520-6C7F-4839-8771-D90C9BA5F177 Q42700913-0115302F-7429-4A23-92A0-8C2A2AAB363D Q58792844-FC9791F4-2ABC-494E-9A98-89A5532BE9C6

P2860

Individualising dual antiplatelet therapy after percutaneous coronary intervention: the IDEAL-PCI registry.

http://www.wikidata.org/entity/Q34439089

description

2014 nî lūn-bûn

@nan

2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Individualising dual antiplate ...... ntion: the IDEAL-PCI registry.

@ast

Individualising dual antiplate ...... ntion: the IDEAL-PCI registry.

@en

Individualising dual antiplate ...... ntion: the IDEAL-PCI registry.

@nl

type

label

Individualising dual antiplate ...... ntion: the IDEAL-PCI registry.

@ast

Individualising dual antiplate ...... ntion: the IDEAL-PCI registry.

@en

Individualising dual antiplate ...... ntion: the IDEAL-PCI registry.

@nl

prefLabel

Individualising dual antiplate ...... ntion: the IDEAL-PCI registry.

@ast

Individualising dual antiplate ...... ntion: the IDEAL-PCI registry.

@en

Individualising dual antiplate ...... ntion: the IDEAL-PCI registry.

@nl

P1433

Q34439089-B61543B9-28AB-4B77-A22F-ADC53943AF6A

P1476

Q34439089-591E8ECA-5727-433E-9748-73498E9AAA40

P2093

Q34439089-0B9A37B8-DCC9-491D-A1A6-1B7CB57BB0B4

Q34439089-8D2C36C4-A7CB-4FEF-89D6-ADD5F50F192B

Q34439089-A6390291-3394-4CCC-9AC4-E07294D72612

Q34439089-D151819E-8CF2-4D16-93AA-A7CBDEF76ACB

Q34439089-F1FE7F6F-15FE-40E5-8B42-57DFCFC52430

P2860

Q34439089-012EFD3A-BCDA-4ECA-90EF-4662A6841431

Q34439089-037888B5-3871-4C7E-A594-15882B248B99

Q34439089-04B84E01-3516-4647-8786-57D87355BD95

Q34439089-22C3D1E4-7B14-4B6F-A1E8-AF15C7570AA8

Q34439089-2D40132A-3B0E-49D9-AFAB-4CFF462A50EC

Q34439089-49786E52-A2AC-4731-BF8C-D73596B2AED8

Q34439089-4D8A53AC-A3BE-45CE-80A7-E1405B087FDF

Q34439089-4FEA59D3-514F-433C-9940-0FC6678A9A00

Q34439089-510FFE9D-A5E0-4F0B-B5F2-56D82FF6BBE2

Q34439089-57812B76-F4D0-4B5A-9182-BAA58D50DB5A

P304

Q34439089-307C3E41-7A31-4580-B63D-B366CD8DCAB6

P31

Q34439089-20A7D222-F2DD-4A2E-9DC2-BF52D476A7D8

P356

Q34439089-C42359F9-586E-4D21-A5E8-4B24995B99A5

P433

Q34439089-BCBBA569-DC55-4661-B7F4-2612A60E77AF

P478

Q34439089-556F8BB1-97AA-4FA1-8D02-3C3FC4008AE5

P50

Q34439089-0A179AF0-CEC1-4910-9986-3371208D1351

P577

Q34439089-E8069BCC-E725-4E13-A255-B92D76665FD8

P5875

Q34439089-208BCF11-B582-46E1-9257-A04BEA32B28E

P698

Q34439089-6835FAD3-7014-4C83-B652-FD6E4BD56BD5

P932

Q34439089-779F018E-FC00-41BC-ADD1-482596B691FD

P356

BMJOPEN-2014-005781

P1433

P1476

Individualising dual antiplate ...... ntion: the IDEAL-PCI registry.

@en

P2093

Andrea Podczeck-Schweighofer

http://www.w3.org/2001/XMLSchema#string

Cornelia Dechant

http://www.w3.org/2001/XMLSchema#string

Günter Christ

http://www.w3.org/2001/XMLSchema#string

Katharina Grohs

http://www.w3.org/2001/XMLSchema#string

Marcel Francesconi

http://www.w3.org/2001/XMLSchema#string

P2860

Consensus and update on the definition of on-treatment platelet reactivity to adenosine diphosphate associated with ischemia and bleeding

Multiple electrode aggregometry: a new device to measure platelet aggregation in whole blood

Bivalirudin during primary PCI in acute myocardial infarction

Ticagrelor versus clopidogrel in patients with acute coronary syndromes

Roles and interactions among protease-activated receptors and P2ry12 in hemostasis and thrombosis

Efficacy and safety of intensified antiplatelet therapy on the basis of platelet reactivity testing in patients after percutaneous coronary intervention: systematic review and meta-analysis.

Effect of platelet inhibition with cangrelor during PCI on ischemic events.

Clinical end points in coronary stent trials: a case for standardized definitions.

Expert position paper on the role of platelet function testing in patients undergoing percutaneous coronary intervention.

Protease activated receptor-1 (PAR-1) mediated platelet aggregation is dependent on clopidogrel response.

P304

e005781

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/BMJOPEN-2014-005781

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P50

Jolanta M Siller-Matula

P577

2014-10-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

267734834

http://www.w3.org/2001/XMLSchema#string

P698

25361837

http://www.w3.org/2001/XMLSchema#string

P932

4216867

http://www.w3.org/2001/XMLSchema#string